PAUL SCHORR: Open Payments
NPI 1063546828 · CANAL WINCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 83 payments from 20 companies in 2025. Trend: 2023 $1,257 · 2024 $880 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $313 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $171 |
| Novo Nordisk Inc | 9 | $136 |
| PFIZER INC. | 7 | $121 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Corcept Therapeutics | 2 | $46 |
| Exact Sciences Corporation | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
Products named: Kerendia, QULIPTA, UBRELVY, NURTEC ODT, Ozempic, AIRSUPRA, VRAYLAR, Auvelity.
Industry payments across OH — which companies pay providers there.
